| Literature DB >> 34945106 |
Pierre Huette1, Pierre-Grégoire Guinot2, Guillaume Haye1, Mouhamed Djahoum Moussa3, Christophe Beyls1, Mathieu Guilbart1, Lucie Martineau1, Hervé Dupont1, Yazine Mahjoub1, Osama Abou-Arab1.
Abstract
We aimed to assess variations in the portal vein pulsatility index (PI) during mechanical ventilation following cardiac surgery.Entities:
Keywords: cardiac surgery; echography; mechanical ventilation; portal vein pulsatility; venous congestion
Year: 2021 PMID: 34945106 PMCID: PMC8706622 DOI: 10.3390/jcm10245810
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Baseline demographic data.
| Variables | Overall Population ( |
|---|---|
| Age—years | 69 (61–77) |
| Male sex—n (%) | 16 (55) |
| BMI—kg m−2 | 27.5 (24.4–30.1) |
| Surgery type—n (%) | |
| Valve replacement | 15 (52) |
| Isolated CABG | 5 (17) |
| Mitral valve surgery | 7 (24) |
| Combined surgery | 1 (3) |
| Other | 1 (3) |
| Medical history n (%) | |
| Hypertension | 22 (76) |
| Diabetes | 8 (21) |
| Dyslipidemia | 13 (45) |
| Smokers | 8 (28) |
| Baseline LVEF (%) | 63 (55–66) |
| Baseline TAPSE (mm) | 21 (16–26) |
| Respiratory characteristics at baseline | |
| Lung compliance, cmH2O−1 | 49 (41–60) |
| Tidal volume, mL k−1 | 6.4 (5.5–6.8) |
| PaO2/FiO2 | 440 (360–510) |
| Respiratory rate (/min) | 15 (14–16) |
| Driving pressure; cmH2O | 10 (7–11) |
| ASA score (II/III) (n) | 3/26 |
| Logistic Euroscore—% | 6 (4–10) |
| SAPS II | 28 (24–40) |
| Biologic data at baseline | |
| Temperature—°C | 36.3 (36.2–36.6) |
| pH | 7.38 (7.34–7.40) |
| PaCO2—mmHg | 40 (36–44) |
| Lactate—mmol·L−1 | 1.3 (1.1–1.5) |
Values are presented as mean ± SD or numbers (%). ASA: American Society of Anesthesiologists; BMI: body mass index expressed as the ratio of weight to height; CABG: coronary artery bypass graft; LVEF: Left ventricular ejection fraction; SAPS: simplified acute physiology score. TAPSE: Tricuspid annular plane systolic excursion.
Figure 1Flowchart.
Evolution of the clinical, echocardiographic, and hepatic parameters after PEEP incrementation.
| Variables | PEEP 0 | PEEP 5 | PEEP 10 | PEEP 15 | |
|---|---|---|---|---|---|
| Clinical parameters | |||||
| Lung compliance (mL/cmH2O) | 44 (36–53) | 48 (40–59) | 24 (15–20) | 18 (15–20) | <0.0001 |
| HR (bpm) | 80 (65–93) | 76 (63–126) | 82 (61–93) | 82 (90) | 0.089 |
| SAP (mmHg) | 115 (109–130) | 119 (101–126) | 112 (92–133) | 97 (75–117) | <0.0001 |
| DAP (mmHg) | 62 (54–71) | 55 (49–67) | 57 (49–65) | 51 (45–65) | <0.0001 |
| MAP (mmHg) | 79 (72–90) | 79 (66–87) | 77 (60–86) | 64 (56–81) | 0.008 |
| PPV (%) | 10 (8–13) | 12 (8–15) | 15 (8–20) | 16 (11–22) | <0.0001 |
| CVP (mmHg) | 6 (4–10) | 7 (5–10) | 11 (8–13) | 12 (9–15) | 0.002 |
| Echocardiographic parameters | |||||
| SV (mL) | 52 (50–55) | 39 (31–46) | 35 (39–36) | 30 (25–45) | <0.0001 |
| CI (L min−1 m−2) | 2.2 (2.07–2.42) | 1.7 (2.12) | 1.6 (1.4–2.2) | 1.2 (1.0–1.8) | <0.0001 |
| TAPSE (mm) | 10 (8–12) | 7 (5–12) | 8 (7–10) | 7 (4–8) | 0.125 |
| S wave (m/s) | 8.7 (11.6–12.6) | 7.3 (6.4–7.8) | 7.3 (6.4–7.7) | 5.6 (4.3–6.7) | 0.194 |
| IVC collapsibility (%) | 22 (10–32) | 30 (24–38) | 13 (6–18) | 9 (4–19) | <0.001 |
| IVC max (mm) | 15 (14–19) | 20 (14–22) | 19 (17–21) | 19 (17–21) | <0.001 |
| IVC min (mm) | 12 (11–14) | 17 (13–20) | 17 (14–19) | 18 (15–20) | <0.001 |
| Hepatic hemodynamics | |||||
| S/D ratio | 2.0 (1.30–2.99) | 1.74 (1.22–1.88) | 1.43 (1.19–1.56) | 1.08 (0.92–1.34) | <0.0001 |
| Portal vein diameter (cm) | 0.49 (0.44–0.58) | 0.55 (0.51–0.61) | 0.48 (0.41–0.57) | 0.55 (0.47–0.64) | 0.081 |
| The portal vein pulsatility index (%) | 9 (5–15) | 15 (5–22) | 34 (23–44) | 45 (25–49) | <0.0001 |
CI: cardiac index; CVP: central venous pressure; DAP: diastolic arterial pressure; HR: heart rate expressed in beats per minutes (bpm); MAP: mean arterial pressure; PEEP: positive end-expiratory pressure; PPV: pulse pressure variation; SAP: systolic arterial pressure; SV: stroke volume; TAPSE: tricuspid annular plane systolic excursion. Pulsatility index (%) was expressed as follows: 100 × (maximal velocity − minimal velocity)/maximal velocity. Comparisons were performed using Wilcoxon rank sum test.
Figure 2Systemic and hepatic hemodynamic changes after PEEP incrementation: (A) changes in CVP with changes in PEEP; (B) changes in the pulsatility index (%) with changes in PEEP; (C) changes in stroke volume with changes in PEEP; (D) changes in Crs with changes in PEEP. Crs: compliance of the respiratory system; CVP: central venous pressure; PEEP: positive end-expiratory pressure.
Correlations between variations in the portal flow pulsatility fraction and stroke volume (SV) following PEEP incrementation.
| Variables | SVPEEP 0 | SVPEEP 5 | SVPEEP 10 | SVPEEP 15 |
|---|---|---|---|---|
| PI | −0.334 * | −0.350 * | −0.123 * | −0.318 * |
| MAP | 0.126 | 0.178 | 0.237 | 0.378 |
| S wave | 0.440 * | 0.418 * | 0.479 | 0.425 * |
| TAPSE | 0.185 | 0.654 * | 0.382 * | 0.393 * |
MAP: mean arterial pressure; PEEP: positive end-expiratory pressure; PF: portal flow pulsatility fraction; SV: stroke volume; TAPSE: tricuspid annular plane systolic excursion. Portal vein pulsatility index (PI) (%) was expressed as follows: 100 × (maximal velocity − minimal velocity)/maximal velocity. Spearman’s correlation analysis was used to identify the correlations. *: p value < 0.05.